News & Sentiment
LINC Investors Have Opportunity to Lead Lincoln Educational Services Corporation Securities Fraud Lawsuit
NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lincoln Educational Services Corporation (NASDAQ: LINC) between May 11, 2026 and August 9, 2026, inclusive (the "Class Period"), of the important November 10,...
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
1,036 articles
📰
ARC Cloud and Compal Forge Strategic Partnership to Accelerate Large-Scale AI Infrastructure
The MOU outlines a global strategic collaboration spanning advanced AI computing systems, high-performance GPU clusters and next-generation data...
📰
Where Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth Engine
Jazz Pharmaceuticals' strategy is starting to pay dividends.
Lockheed Martin to Add Air-Launched Hypersonic Missile to the American Arsenal of Freedom
TROY, Ala., Oct. 27, 2026 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) has been awarded a $694M contract from the U.S. Air Force for production of the...
📰
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
The stocks listed here yield up to 5.8%.
📰
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
The stocks listed here yield up to 5.8%.
📰
Nvidia Plays Kingmaker Again. Why the Meta Deal Is a Winning Move.
Nvidia will invest $3 billion in Meta Platforms as part of a larger partnership.
📰
Wave Life Sciences (WVE) Q3 2026 Earnings Call Transcript
RNA medicine company advances obesity and lung disease programs with $431M cash runway.
📰
IQVIA (IQV) Q3 2026 Earnings Call Transcript
Revenue hit $4.4 billion with 8% growth; net new bookings surged 15% year over year.
📰
Kiniksa Pharmaceuticals: 3 Key Takeaways for Long-Term Investors
Profit growth is outpacing revenue gains, giving the company firepower to advance pipeline candidates without diluting shareholders.
📰
Twist Bioscience Rallies as Investors Revisit Growth Outlook Ahead of Earnings - Quiver Quantitative
Twist Bioscience Rallies as Investors Revisit Growth Outlook Ahead of Earnings Quiver Quantitative
Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y
ECL's Q3 earnings increase 5% to $2.18 per share, while revenues jump 13%, driven by strong Water and Life Sciences growth and accelerating digital...
Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y
ECL's Q3 earnings increase 5% to $2.18 per share, while revenues jump 13%, driven by strong Water and Life Sciences growth and accelerating digital...
Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y
ECL's Q3 earnings increase 5% to $2.18 per share, while revenues jump 13%, driven by strong Water and Life Sciences growth and accelerating digital...
A World First, Beacon AI Flies Murdock Its AI Pilot Assistant System Aboard Operational USAF Tankers
Five flights, three airfields, three KC-46A Pegasus aircraft, and approx 20 hours of flight time, under an AFWERX Tactical Funding Increase with Air...
📰
Pharming (PHAR) Q3 2026 Earnings Call Transcript
Revenue grew 21% year-over-year as RUCONEST stabilized and Joenja expanded internationally.
📰
Nautilus (NAUT) Q3 2026 Earnings Call Transcript
Cash reserves extend runway into early 2028 as proteoform assay pipeline accelerates.
Seatrium and Karpowership to Jointly Develop Floating Power Solutions and Digital Infrastructure, Supporting Singapore and Southeast Asia's Energy Resilience
Memorandum of Understanding (MoU) announced at Singapore International Energy Week 2026 Combines Seatrium's offshore engineering expertise with...
📰
Novartis (NVS) Q3 2026 Earnings Call Transcript
Priority brands offset generic erosion as margin expands and pipeline advances.
📰
Kiniksa (KNSA) Q3 2026 Earnings Call Transcript
ARCALYST revenue surged 58% year-over-year as the company raised full-year guidance.
Lockheed Martin Welcomes Dedicated PAC-3® Missile Maintenance Facility in Poland
BRUSSELS, Oct. 27, 2026 /PRNewswire/ -- In coordination with the United States Government, Lockheed Martin is pleased to announce plans to establish...
X-Bow Selected by CoAspire to Provide Booster Motors for U.S. Navy CHAOS Program
ALBUQUERQUE, N.M., Oct. 27, 2026 /PRNewswire/ -- X-Bow Systems Inc (X-Bow®), a U.S. manufacturer of solid rocket motors (SRMs), today announced it...
📰
Repligen (RGEN) Q3 2026 Earnings Call Transcript
BioLife acquisition bolsters cell therapy as chromatography and proteins surge.
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests
WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer...
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests
WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer...
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests
WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer...
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests
WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer...
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on...
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on...
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on...
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on...
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
LLY, NVS, JNJ and ABBV offer arthritis drug growth potential through rising sales, regulatory approvals and clinical advances across inflammatory...
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
HCA's Q3 earnings and revenues beat estimates on higher admissions and ER visits, while rising costs and fewer surgeries temper growth.
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
HCA's Q3 earnings and revenues beat estimates on higher admissions and ER visits, while rising costs and fewer surgeries temper growth.